Aurora kinase A inhibition plus Tumor Treating Fields suppress glioma cell proliferation in a cilium-independent manner
Tumor Treating Fields (TTFields) extend the survival of glioblastoma (GBM) patients by interfering with a broad range of tumor cellular processes. Among these, TTFields disrupt primary cilia stability on GBM cells. Here we asked if concomitant treatment of TTFields with other agents that interfere w...
Main Authors: | Jia Tian, Julianne C. Mallinger, Ping Shi, Dahao Ling, Loic P. Deleyrolle, Min Lin, Habibeh Khoshbouei, Matthew R. Sarkisian |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-07-01
|
Series: | Translational Oncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523324000834 |
Similar Items
-
Tumor Treating Fields Suppression of Ciliogenesis Enhances Temozolomide Toxicity
by: Ping Shi, et al.
Published: (2022-03-01) -
HDAC6 Signaling at Primary Cilia Promotes Proliferation and Restricts Differentiation of Glioma Cells
by: Ping Shi, et al.
Published: (2021-04-01) -
Investigation of the Impact of Foretinib on AURKA and AURKB Expression in T98 Glioblastoma Cell Line
by: Mansour Moghimi, et al.
Published: (2019-02-01) -
Promising Therapy in Lung Cancer: Spotlight on Aurora Kinases
by: Domenico Galetta, et al.
Published: (2020-11-01) -
Ubiquitin-mediated degradation of Aurora kinases
by: Catherine eLindon, et al.
Published: (2016-01-01)